Upload
po-lindara
View
201
Download
1
Embed Size (px)
DESCRIPTION
Briefly discussion on TED
Citation preview
Thyroid Eye Disease
Ea RaksmeyPo Lindara
Outline
• Introduction to TED• Epidemiology• Pathogenesis • Clinical features
– Systemic – Ocular
– Diagnosis– Prognosis– Management:
– Supporting care– Medical– Surgical
Introduction• TED or Graves ophthalmopathy • Auto-immune • Excessive secretion of thyroid hormones • Mostly associated with:
– Graves hyperthyroidism – Hashimoto thyroiditis– Euthyroidism
• Characteristics – Lid retraction – Lid lag– Proptosis– Restcrictive extraocular myopathy – ON compressoin
Epidemiology
• Female 4x• Smokers 7x• 3rd-4th decade of life • Associated with:
– 90% Graves hyperthyroidism – 6% Euthyroidism – 3% Hashimoto thyroiditis – 1% Primary hypothyroidism
• Onset: – 20% of TED is diagnosed same time as hyperthyroidism – 60% of eye disease occur 1 year after thyroid disease – Only 30% of hyperthyroidism TED
Pathogenesis
Fibroblast
Adipogenesis Fat HypertrophySynthesis of GAG
Inflammatory reaction
IgGTSH-R mRNA synthesis
T-Cells Stimulation
Systemic Features
Ocular Features• Symptoms:
– Grittiness – Photophobia – Lacrimation – Retrobulbar discomfort
• Signs: – Lid retraction – Lid lag– Restrictive EOM movement– Proptosis– ON compression
• 2 Stages: – Congestive: remits within 3 years, 10% long term problems– Fibrotic: restrictive movement
Lid Retraction• 50%• Fibrotic contracture of levator:
– Worse in downgaze
• Secondary overreaction of levator-SR complex:– Secondary hypotrophia caused by fibrosis of IR– Worse in upgaze
• Humorally induced overreaction of Müller muscle:– Sympathetic stimulation by thyroid hormones
• 3 signs:
Dalrymple Sign Kocher Sign Von Graefe Sign
Proptosis
• Axial • Uni/bilateral • Symmetrical/asymmetrical • Inflammatory cells infiltration GAG fluid retention
increase orbital pressure proptosis
Restrictive EOM
• 30-50%• Inflammation of EOM
– cells infiltration retain fluid swelling compression– Muscle fibers degeneration fibrosis
• Elevation defect: IR fibrosis• Abduction defect: MR fibrosis• Depression defect: SR fibrosis• Adduction: LR fibrosis
ON Compression • Uncommon but serious • Inflammation of EOM cells infiltration GAG fluid
retention orbital pressure compression • +/- proptosis • Signs:
– Reduced VA +/- RAPD, color desaturation– VF defect: central or paracentral, increased IOP (confused with POAG)– OD is normal, might swollen and rarely atrophic
Enlargement of recti with tendon sparing
Diagnosis• 2 of 3 sign present
– Thyroid dysfunction:• Grave• Hashimoto• Thyroid Ab, TSH-R, TBII, TSI, antimicrosomal
– Orbital sign as above– Rx evidencen of uni/bilateral fusiform
enlargement of 1 or more• MR• IR• SR/ elevator complex
• If only 1 orbital sign; observe
Differential diagnosis
• VEIIN +Miscellous:– Vascular– Endocrine– Infection– Inflammation– Neoplastic– Miscellous
Prognosis– self-limiting disease average lasts 1 year– 2-3 years in smoker, 7 x develop the orbital– Reactivation 5-10%– Poor prognosis feature include:
• smoking• rapidly progressive orbitopathy• dermopathy
– Most patient require only support care– Intervention may be necessary if inflammation
is severe– long-term F/U:
• Visual loss from ON is uncommon• >50% thought that their looked abnormal• 38% were dissatisfied
Management
Treatement
• Supportive care:– Stop smoking– Lubricant (methylcellulose)– cool compress– head elevated– fluid diet– Prism lens– Botulinum toxin Mϋller muscle– 5% guanthidine (worse by side effect)
Medication• Corticosteroid:
– to suppress immune properties– Indication (active inflammation) :
• Erythema• Eyelid edema• Compressive Opticneuropathy
– starting:• 60-100mg orally• short-term pulse IV; 1g daily 1 week to 2
months• retrobulbar or peribulbar 20mg /0,5cc
triamcinolone weekly for 4 weeks(benificial on diplopia and EOM size without significan s.e.)
Medication• Cyclosporin :
– compare to steroid (21% vs 61%)– very limited role– s.e. nephrotoxicity, hypertension
• Methothrexate:– second-line treatment with recalcitrant TED
to control the clinical profile and delay surgery untill the disease stability
• Ticlonidine, IV immune globulin• Somatostatin analogue
Radiation therapy
– Mechanism effect is unclear– induce terminal differentiation of
fibroblast– kill tissue-bound monocyte– clinical trial design show no statistically
significant compared with the natural history of the diseas
– Should avoid with: diabetes, vasculitis, may exacerbate retinopathy.
Surgery
• Orbital decompression• Strabismus surgery• Eyelid retraction repair
Orbital decompression
• to create more space for the swollen tissue by expanding the wall of the orbit
• Indication:– CON– excessive proptosis :
• Globe subluxation• Cornea ulcer• Steroid depending• Intractable pain• Cosmetic
Strabismus surgery
• stable at least 6 months• to achieve binocular vision in primary
and downgaze position• most frequent is recession MR or IR
(6-7mm), no more than 3 muscle
Eyelid retractor retraction
• after orbital decompression done• indication:
– ocular discomfort– keratitis, including corneal ulceration, – globe subluxation,– cosmesis
Message home
– Eyelid retraction is the most common feature of TED
– TED is the most common uni/bilateral proptosis, markedly asymmetric
– 90% hyper, but 6% euthyroid– Severity is not parallel to serum level (TSH,
T3, T4..), but the smoking indeed 7x– Urgent care may be require for COM,
severe proptosis cornea decompensat– Surgery should be in order: Orbital
decompression Strabismus eyelid correction
Thank you!!